Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
less decrease » mean decrease (Expand Search), we decrease (Expand Search), levels decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 1,081 - 1,100 results of 1,542 for search 'significantly ((((((less decrease) OR (largest decrease))) OR (teer decrease))) OR (nn decrease))', query time: 0.36s Refine Results
  1. 1081
    Typical structure of a centrifugal nozzle [25].

    Typical structure of a centrifugal nozzle [25]. by Yanyu Cui (19173181)

    Published 2025
    “…However, at 1.0 MPa, the effect of blending ratio on atomization becomes less significant, with the difference in liquid film thickness reduced to 4.2%. …”
    Save to List
    Saved in:
  2. 1082
    Cross-sectional velocity distribution contour.

    Cross-sectional velocity distribution contour. by Yanyu Cui (19173181)

    Published 2025
    “…However, at 1.0 MPa, the effect of blending ratio on atomization becomes less significant, with the difference in liquid film thickness reduced to 4.2%. …”
    Save to List
    Saved in:
  3. 1083
    Mesh generation details.

    Mesh generation details. by Yanyu Cui (19173181)

    Published 2025
    “…However, at 1.0 MPa, the effect of blending ratio on atomization becomes less significant, with the difference in liquid film thickness reduced to 4.2%. …”
    Save to List
    Saved in:
  4. 1084
    Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.pdf

    Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  5. 1085
    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  6. 1086
    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  7. 1087
    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  8. 1088
    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  9. 1089
    Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  10. 1090
    Image 9_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 9_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  11. 1091
    Table 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.xlsx

    Table 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.xlsx by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  12. 1092
    Image 8_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 8_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  13. 1093
    Image 5_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 5_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  14. 1094
    Image 2_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 2_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  15. 1095
    Image 3_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 3_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  16. 1096
    Image 4_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 4_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  17. 1097
    Image 11_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 11_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  18. 1098
    Image 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  19. 1099
    Image 10_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 10_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  20. 1100
    Image 7_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 7_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:

Search Tools: